Correlation Between Multicell Techs and Biostage
Can any of the company-specific risk be diversified away by investing in both Multicell Techs and Biostage at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Multicell Techs and Biostage into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Multicell Techs and Biostage, you can compare the effects of market volatilities on Multicell Techs and Biostage and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Multicell Techs with a short position of Biostage. Check out your portfolio center. Please also check ongoing floating volatility patterns of Multicell Techs and Biostage.
Diversification Opportunities for Multicell Techs and Biostage
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Multicell and Biostage is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Multicell Techs and Biostage in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biostage and Multicell Techs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Multicell Techs are associated (or correlated) with Biostage. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biostage has no effect on the direction of Multicell Techs i.e., Multicell Techs and Biostage go up and down completely randomly.
Pair Corralation between Multicell Techs and Biostage
If you would invest 420.00 in Biostage on September 5, 2024 and sell it today you would earn a total of 0.00 from holding Biostage or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 1.61% |
Values | Daily Returns |
Multicell Techs vs. Biostage
Performance |
Timeline |
Multicell Techs |
Biostage |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Multicell Techs and Biostage Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Multicell Techs and Biostage
The main advantage of trading using opposite Multicell Techs and Biostage positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Multicell Techs position performs unexpectedly, Biostage can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biostage will offset losses from the drop in Biostage's long position.Multicell Techs vs. Pmv Pharmaceuticals | Multicell Techs vs. MediciNova | Multicell Techs vs. Pharvaris BV | Multicell Techs vs. PepGen |
Biostage vs. Biotron Limited | Biostage vs. biOasis Technologies | Biostage vs. Covalon Technologies | Biostage vs. Mosaic Immunoengineering |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |